Related Experiment Videos
[Neonatal spasms--a review of symptoms, etiology, therapy and prognosis]
Insights
Newborn seizures signal underlying conditions, with subtle seizures being most common. Prompt diagnosis and treatment are crucial for a better prognosis, with phenobarbital as a first-choice anticonvulsant.
Area of Science:
- Neonatal neurology
- Pediatric seizures
- Clinical neurophysiology
Context:
- Neonatal seizures are critical indicators of serious underlying pathologies.
- Subtle seizures represent the most frequent neurological presentation in newborns.
- Ischemic encephalopathy is a leading cause, while hypocalcemia is a primary metabolic factor.
Purpose:
- To outline the diagnostic approach to neonatal seizures.
- To differentiate epileptic from non-epileptic episodic events.
- To establish treatment guidelines and prognostic indicators for neonatal seizures.
Summary:
- Neonatal seizures manifest in various patterns, with subtle seizures being most common, often linked to ischemic encephalopathy.
- While hypocalcemia is a key metabolic cause, hypoglycemia plays a minor role in seizure pathogenesis.
- Accurate diagnosis of the underlying cause is paramount for effective treatment and improved outcomes.
Impact:
- Highlights the importance of timely diagnosis and targeted treatment for improving neonatal outcomes.
- Emphasizes the role of phenobarbital as the primary anticonvulsant therapy.
- Underscores the prognostic value of electroencephalography (EEG) and neurological evaluation in guiding treatment duration.
Abstract:
Seizures in the newborn are a distinctive sign of underlying disease. Different convulsive patterns are described. The most common neurologic syndrome consists of subtle seizures. The most important cause is ischemic encephalopathy. Hypocalcemia is the main metabolic disease. Hypoglycemia seems not to be of special relevance for pathogenesis of newborn seizures. Other episodic symptoms of non-epileptic origin should be considered in the differential diagnosis. It is critical to diagnose the cause and to treat it, since the prognosis depends on the underlying disturbance. Phenobarbital is the anticonvulsive drug of first choice. Duration of treatment is determinated of an preexisting brain damage. Newborns with normal neurological evaluation don't need any longer anticonvulsive treatment after cessation of seizures. The EEG is an important prognostic tool.